Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01568177
What this trial is testing

Cardiac Autonomic Function in Women with Microvascular Coronary Dysfunction

Who this might be right for
Microvascular Coronary Dysfunction
Cedars-Sinai Medical Center 105
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Testing effectiveness (Phase 2)Study completedNCT02894151
What this trial is testing

Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients

Who this might be right for
Clinically Diagnosed Endometriotic Patient Was Defined as a Woman Who Has Pelvic Pain and at Least One Evidence of PV or TVS
Chulalongkorn University 50
Early research (Phase 1)Study completedNCT00935831
What this trial is testing

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Who this might be right for
Kidney Disease
GlaxoSmithKline 12
Not applicableStudy completedNCT00778557
What this trial is testing

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions

Who this might be right for
Healthy
Ranbaxy Laboratories Limited 35
Not applicableStudy completedNCT07013422
What this trial is testing

The Effectiveness of Psychoeducational Intervention in Reducing Anxiety, Depression, and Symptom Burden Among Omani Women Diagnosed With Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Sultan Qaboos Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT02178722
What this trial is testing

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Who this might be right for
Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial CancerHead and Neck Cancer+11 more
Incyte Corporation 444
Early research (Phase 1)Looking for participantsNCT07470853
What this trial is testing

MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Who this might be right for
PROCPlatinum Resistant Ovarian CancerEndometrial Cancer
Whitehawk Therapeutics, Inc. 265
Early research (Phase 1)Study completedNCT00886353
What this trial is testing

Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)

Who this might be right for
Pulmonary DiseasesCardiovascular DiseasesKidney Diseases+1 more
Apeiron Biologics 22
Testing effectiveness (Phase 2)Study completedNCT04799639
What this trial is testing

Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer

Who this might be right for
Cervical CancerChemotherapy EffectProgrammed Cell Death 1 Receptor / Antagonists & Inhibitors+1 more
Sun Yat-sen University 47
Large-scale testing (Phase 3)UnknownNCT01138839
What this trial is testing

Dexamethasone Efficacy in HELLP I Syndrome

Who this might be right for
HELLP Syndrome
Universidad del Valle, Colombia 160
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Large-scale testing (Phase 3)UnknownNCT03664895
What this trial is testing

Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)

Who this might be right for
Breast Cancer Invasive
Seoul National University Hospital 224
Early research (Phase 1)Study completedNCT00003107
What this trial is testing

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Indiana University
Large-scale testing (Phase 3)Study completedNCT00381901
What this trial is testing

Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
National Cancer Institute, France 3,400
Not applicableStudy completedNCT01322165
What this trial is testing

National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions

Who this might be right for
Marfan SyndromeTurner SyndromeEhlers-Danlos Syndrome+9 more
National Heart, Lung, and Blood Institute (NHLBI) 3,706
Not applicableStudy completedNCT01952600
What this trial is testing

Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)

Who this might be right for
Chronic Kidney Disease
Arbor Research Collaborative for Health 215
Early research (Phase 1)Study completedNCT00816764
What this trial is testing

The Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer

Who this might be right for
CarcinomaOvarian CancerOvarian Diseases+1 more
Astellas Pharma Inc 18
Testing effectiveness (Phase 2)Study completedNCT00537836
What this trial is testing

ZK283197 for Treatment of Vasomotor Symptoms

Who this might be right for
Vasomotor System
Bayer 116
Early research (Phase 1)Ended earlyNCT05861947
What this trial is testing

Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

Who this might be right for
RelapseAdvanced Malignant NeoplasmNon Small Cell Lung Cancer+5 more
Aurigene Discovery Technologies Limited 21
Next Page